IMALT

The Improving Medication Adherence in Children who had a Liver Transplant (iMALT) study will test a tailored telemetric intervention to reduce rejection rates by improving erratic medication adherence (nonadherene) to medications in pediatric liver transplant recipients. The study is funded through grant number 1 U01 DK119200-01 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Also known as: The Emmes Company, The Emmes Company, LLC